Home  »  Industry   »  Elevation Oncology Inc. (ELEV): Up ahead of its co...

Elevation Oncology Inc. (ELEV): Up ahead of its competition

For the readers interested in the stock health of Elevation Oncology Inc. (ELEV). It is currently valued at $2.16. When the transactions were called off in the previous session, Stock hit the highs of $1.47, after setting-off with the price of $1.09. Company’s stock value dipped to $1.09 during the trading on the day. When the trading was stopped its value was $1.43.Recently in News on March 14, 2023, Elevation Oncology to Present at the American Association of Cancer Research (AACR) Annual Meeting 2023. – Company plans to highlight preclinical proof-of-concept data for EO-3021 in an oral presentation at the New Drugs on the Horizon special session. You can read further details here

Elevation Oncology Inc. had a pretty Dodgy run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $4.6099 on 05/25/22, with the lowest value was $0.7229 for the same time period, recorded on 01/06/23.

From Robots to Self-Driving Cars: 5 AI Stocks to Consider for Your Portfolio

The artificial intelligence (AI) revolution is already here and it's about to change everything we know about everything. With the global market for AI projected to grow from $137 billion in 2022 to over $1.81 trillion by 2030, there's never been a better time to invest in this burgeoning industry. That's why we've compiled a list of the Top 5 AI Stocks to Buy for 2023. These companies are at the forefront of the AI revolution, and have the potential to deliver huge returns to investors like you.

Get our free report, "Top 5 AI Stocks to Buy for 2023".


Elevation Oncology Inc. (ELEV) full year performance was -18.39%

Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Elevation Oncology Inc. shares are logging -53.09% during the 52-week period from high price, and 199.17% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $0.72 and $4.61.

The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 12298494 for the day, which was evidently higher, when compared to the average daily volumes of the shares.

When it comes to the year-to-date metrics, the Elevation Oncology Inc. (ELEV) recorded performance in the market was 127.65%, having the revenues showcasing 139.98% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 36.94M, as it employees total of 48 workers.

Analysts verdict on Elevation Oncology Inc. (ELEV)

During the last month, 0 analysts gave the Elevation Oncology Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.

According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 1.0427, with a change in the price was noted +1.02. In a similar fashion, Elevation Oncology Inc. posted a movement of +92.65% for the period of last 100 days, recording 194,931 in trading volumes.

Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for ELEV is recording 0.60 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.60.

Elevation Oncology Inc. (ELEV): Technical Analysis

Raw Stochastic average of Elevation Oncology Inc. in the period of last 50 days is set at 90.87%. The result represents improvement in oppose to Raw Stochastic average for the period of the last 20 days, recording 89.30%. In the last 20 days, the company’s Stochastic %K was 70.79% and its Stochastic %D was recorded 59.50%.

Let’s take a glance in the erstwhile performances of Elevation Oncology Inc., multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be pessimistic, given the fact the metric is recording 127.65%. Additionally, trading for the stock in the period of the last six months notably improved by 67.65%, alongside a downfall of -18.39% for the period of the last 12 months. The shares increased approximately by 62.61% in the 7-day charts and went down by 116.27% in the period of the last 30 days. Common stock shares were driven by 139.98% during last recorded quarter.

Leave a Comment

Your email address will not be published. Required fields are marked *

On Key

Related Posts